Skip to main content

Table 2 Alternative Anti-Malarial Prescribing in the Presence and Absence of ACT Stock

From: Taking stock: provider prescribing practices in the presence and absence of ACT stock

Country, Year

% (No.) of patients diagnosed with uncomplicated malaria/fever and prescribed Alternative (non-ACT) Anti-Malarial

 

At all facilities,

% (n)

At facilities with ACT stock, % (n)

At facilities with no ACT stock, % (n)

% differencea

(95% Confidence Intervalc; p-value)

Kenya, 2006 [19]

50.5% (475/940)

47.8%

(414/866)

82.4%

(61/74)

-34.6%

(-44.6%, -24.6%; p < 0.001)

Kenya, 2010 [14]

8.6% (183/2125)

8%

(162/2025)

21%

(21/100)

-13%

(-21.6%, -4.4%; p < 0.001)

Uganda, 2007 [18]

< 5 yrs

< 5 yrs

< 5 yrs

< 5 yrs

 

19.5%

(90/461)

16.4%

(70/428)

60.6%

(20/33)

-44.2%

(-62.9%, -25.6%; p < 0.001)

 

≥ 5 yrs

≥ 5 yrs

≥ 5 yrs

≥ 5 yrs

 

26.7% (197/739)

22.5%

(145/644)

54.7%

(52/95)

-32.2%

(-43.3%, -21.1%; p < 0.001)

Zambia, 2004 [16]

≥ 10 kg

≥ 10 kg

≥ 10 kg

≥ 10 kg

 

72.3% (285/394)

56.8%

(109/192)

87.1% (176/202)

-30.3%

(-39.3%, -21.5%, p < 0.001)

Zambia, 2006 [17]

5-9 kg

5-9 kg

5-9 kg

5-9 kg

 

43.5% (240/552)

24.2%

(85/351)

77.1%

(155/201)

-52.9%

(-60.6%, -45.2%; p < 0.001)

 

≥ 10 kg

≥ 10 kg

≥ 10 kg

≥ 10 kg

 

34.6% (189/547)

17.4% (65/374)

71.7%

(124/173)

-54.3%

(-62.5%, -46.1%; p < 0.001)

Zambia, 2006 [15]b

36.6% (533/1457)

23.1%

(240/1040)

70.3% (293/417)

-47.2%

(-52.4%, -41.9%; p < 0.001)

  1. a Difference is the proportion of patients who received alternative anti-malarials at facilities with ACT stock minus the proportion of patients who received alternative anti-malarials at facilities with no ACT stock
  2. b Analysis restricted to facilities where diagnostics were available, test negative results excluded from analysis
  3. c Confidence interval not adjusted for clustering at facility level